                         SEQUENCE LISTING

<110>  Universit Pierre et Marie Curie
       CNRS
       Caboche, J.
 
<120>  TREATMENT OF MOOD AND ANXIETY DISORDERS

<130>  BCT090303

<160>  30    

<170>  PatentIn version 3.3

<210>  1
<211>  19
<212>  PRT
<213>  artificial

<220>
<223>  Elk-1 docking domain

<400>  1

Ser Pro Ala Lys Leu Ser Phe Gln Phe Pro Ser Ser Gly Ser Ala Gln 
1               5                   10                  15      


Val His Ile 
            


<210>  2
<211>  17
<212>  PRT
<213>  artificial

<220>
<223>  Elk-1 docking domain

<400>  2

Lys Gly Arg Lys Pro Arg Asp Leu Glu Leu Pro Leu Ser Pro Ser Leu 
1               5                   10                  15      


Leu 
    


<210>  3
<211>  18
<212>  PRT
<213>  artificial

<220>
<223>  MSK-1 docking domain

<400>  3

Lys Ala Pro Leu Ala Lys Arg Arg Lys Met Lys Lys Thr Ser Thr Ser 
1               5                   10                  15      


Thr Glu 
        


<210>  4
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  HIV-TAT cell penetrating sequence

<400>  4

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg 
1               5                   10  


<210>  5
<211>  16
<212>  PRT
<213>  artificial

<220>
<223>  Penetratine cell penetrating sequence

<400>  5

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  6
<211>  7
<212>  PRT
<213>  artificial

<220>
<223>  7R cell penetrating sequence

<400>  6

Arg Arg Arg Arg Arg Arg Arg 
1               5           


<210>  7
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  8R cell penetrating sequence

<400>  7

Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210>  8
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  9R cell penetrating sequence

<400>  8

Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   


<210>  9
<211>  10
<212>  PRT
<213>  artificial

<220>
<223>  10R cell penetrating sequence

<400>  9

Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10  


<210>  10
<211>  11
<212>  PRT
<213>  artificial

<220>
<223>  11R cell penetrating sequence

<400>  10

Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg Arg 
1               5                   10      


<210>  11
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  XR cell penetrating sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be any naturally occurring amino acid

<400>  11

Xaa Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210>  12
<211>  8
<212>  PRT
<213>  artificial

<220>
<223>  RX cell penetrating sequence


<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa can be any naturally occurring amino acid

<400>  12

Arg Arg Arg Arg Arg Arg Arg Xaa 
1               5               


<210>  13
<211>  9
<212>  PRT
<213>  artificial

<220>
<223>  XRX cell penetrating sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (9)..(9)
<223>  Xaa can be any naturally occurring amino acid

<400>  13

Xaa Arg Arg Arg Arg Arg Arg Arg Xaa 
1               5                   


<210>  14
<211>  14
<212>  PRT
<213>  artificial

<220>
<223>  XRX cell penetrating sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (8)..(8)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (14)..(14)
<223>  Xaa can be any naturally occurring amino acid

<400>  14

Xaa Arg Arg Arg Arg Arg Arg Xaa Arg Arg Arg Arg Arg Xaa 
1               5                   10                  


<210>  15
<211>  23
<212>  PRT
<213>  artificial

<220>
<223>  DPV15b cell penetrating sequence

<400>  15

Gly Ala Tyr Asp Leu Asp Arg Arg Arg Glu Arg Gln Ser Arg Leu Arg 
1               5                   10                  15      


Arg Arg Glu Arg Gln Ser Arg 
            20              


<210>  16
<211>  14
<212>  PRT
<213>  artificial

<220>
<223>  DPV10 cell penetrating sequence

<400>  16

Ser Arg Arg Ala Arg Arg Ser Pro Arg His Leu Gly Ser Gly 
1               5                   10                  


<210>  17
<211>  16
<212>  PRT
<213>  artificial

<220>
<223>  DPV15 cell penetrating sequence

<400>  17

Leu Arg Arg Glu Arg Gln Ser Arg Leu Arg Arg Glu Arg Gln Ser Arg 
1               5                   10                  15      


<210>  18
<211>  19
<212>  PRT
<213>  artificial

<220>
<223>  DPV1047 cell penetrating sequence

<400>  18

Val Lys Arg Gly Leu Lys Leu Arg His Val Arg Pro Arg Val Thr Arg 
1               5                   10                  15      


Met Asp Val 
            


<210>  19
<211>  16
<212>  PRT
<213>  artificial

<220>
<223>  DPV3 cell penetrating sequence

<400>  19

Arg Lys Lys Arg Arg Arg Glu Ser Arg Lys Lys Arg Arg Arg Glu Ser 
1               5                   10                  15      


<210>  20
<211>  7
<212>  PRT
<213>  artificial

<220>
<223>  SV40 large T antigen NLS sequence

<400>  20

Pro Lys Lys Lys Arg Lys Val 
1               5           


<210>  21
<211>  16
<212>  PRT
<213>  artificial

<220>
<223>  nucleoplasmin NLS sequence

<400>  21

Lys Arg Pro Ala Ala Ile Lys Lys Ala Gly Gln Ala Lys Lys Lys Lys 
1               5                   10                  15      


<210>  22
<211>  15
<212>  PRT
<213>  artificial

<220>
<223>  HIV1rev NLS sequence

<400>  22

Arg Gln Ala Arg Arg Asn Arg Arg Asn Arg Arg Arg Arg Trp Arg 
1               5                   10                  15  


<210>  23
<211>  12
<212>  PRT
<213>  artificial

<220>
<223>  Elk-1 type consensus NES sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (3)..(5)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (7)..(8)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  23

Xaa Leu Xaa Xaa Xaa Leu Xaa Xaa Leu Xaa Leu Xaa 
1               5                   10          


<210>  24
<211>  12
<212>  PRT
<213>  artificial

<220>
<223>  Net  type consensus NES sequence


<220>
<221>  misc_feature
<222>  (1)..(1)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (3)..(5)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (7)..(8)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (10)..(10)
<223>  Xaa can be any naturally occurring amino acid

<220>
<221>  misc_feature
<222>  (12)..(12)
<223>  Xaa can be any naturally occurring amino acid

<400>  24

Xaa Leu Xaa Xaa Xaa Leu Xaa Xaa Leu Xaa Arg Xaa 
1               5                   10          


<210>  25
<211>  12
<212>  PRT
<213>  artificial

<220>
<223>  MAPKK NES sequence

<400>  25

Ala Leu Gln Lys Lys Leu Glu Glu Leu Glu Leu Asp 
1               5                   10          


<210>  26
<211>  12
<212>  PRT
<213>  artificial

<220>
<223>  Net NES sequence

<400>  26

Thr Leu Trp Gln Phe Leu Leu Gln Leu Leu Leu Asp 
1               5                   10          


<210>  27
<211>  12
<212>  PRT
<213>  artificial

<220>
<223>  Elk-1  NES sequence

<400>  27

Thr Leu Trp Gln Phe Leu Leu Gln Leu Leu Arg Glu 
1               5                   10          


<210>  28
<211>  31
<212>  PRT
<213>  artificial

<220>
<223>  selective peptide inhibitor of Elk-1 activation - TAT-DEF-Elk-1

<400>  28

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Ser Pro Ala Lys 
1               5                   10                  15      


Leu Ser Phe Gln Phe Pro Ser Ser Gly Ser Ala Gln Val His Ile 
            20                  25                  30      


<210>  29
<211>  29
<212>  PRT
<213>  artificial

<220>
<223>  selective peptide inhibitor of ELk-1 activation

<400>  29

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Lys Gly Arg Lys 
1               5                   10                  15      


Pro Arg Asp Leu Glu Leu Pro Leu Ser Pro Ser Leu Leu 
            20                  25                  


<210>  30
<211>  30
<212>  PRT
<213>  artificial

<220>
<223>  selective inhibitor of MSK-1 activation

<400>  30

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Lys Ala Pro Leu 
1               5                   10                  15      


Ala Lys Arg Arg Lys Met Lys Lys Thr Ser Thr Ser Thr Glu 
            20                  25                  30  


